TTD Drug ID:
DNC005413
Drug
Information |
Name | N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide | N-hydroxy-4-(3-phenylpropanamido)benzamide | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| Target | Histone deacetylase 1 |  | Inhibitor | [1] | Histone deacetylase 10 |  | Inhibitor | [2] | Histone deacetylase 2 |  | Inhibitor | [1] | Histone deacetylase 4 |  | Inhibitor | [2] | Histone deacetylase 6 |  | Inhibitor | [2] | Histone deacetylase 7 |  | Inhibitor | [2] | Histone deacetylase 8 |  | Inhibitor | [2] | Ref 1 | Eur J Med Chem. 2009 Nov;44(11):4470-6. Epub 2009 Jun 17.Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors. To Reference | Ref 2 | J Med Chem. 2005 Aug 25;48(17):5530-5.Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|